These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22806154)

  • 21. Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB/c mice.
    Jain S; Afley P; Dohre SK; Saxena N; Kumar S
    Vaccine; 2014 Jul; 32(35):4537-4542. PubMed ID: 24950353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection.
    Fu S; Xu J; Li X; Xie Y; Qiu Y; Du X; Yu S; Bai Y; Chen Y; Wang T; Wang Z; Yu Y; Peng G; Huang K; Huang L; Wang Y; Chen Z
    PLoS One; 2012; 7(2):e29552. PubMed ID: 22383953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
    Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
    Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
    Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice.
    Hop HT; Simborio HL; Reyes AW; Arayan LT; Min W; Lee HJ; Kim DH; Chang HH; Kim S
    FEMS Microbiol Lett; 2015 Feb; 362(4):. PubMed ID: 25724777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Res; 2020 Jan; 51(1):6. PubMed ID: 31973749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB/c mice.
    Lin GZ; Yang JT; Wei SC; Chen SE; Huo SD; Ma ZR
    Trop Anim Health Prod; 2018 Jun; 50(5):957-963. PubMed ID: 29492808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with a combination of recombinant Brucella abortus proteins induces T helper immune response and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Wei S; Yang G; Zhang C; Xi L; Zhang J; Cui Y; Hao J; Zhang H; Zhang H
    Microb Biotechnol; 2022 Jun; 15(6):1811-1823. PubMed ID: 35166028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Céspedes S; Cabrera A; Rivers R; González A; Muñoz C; Folch H; Andrews E
    Infect Immun; 2003 Sep; 71(9):4857-61. PubMed ID: 12933826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brucella abortus phosphoglyceromutase and dihydrodipicolinate reductase induce Th1 and Th2-related immune responses.
    Li Z; Zhang H; Zhang J; Xi L; Yang G; Wang S; Zhou Q; Zhang X; Zhang J
    World J Microbiol Biotechnol; 2018 Jan; 34(2):22. PubMed ID: 29302824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
    Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.